Trial | NCT01357538  Report issue

Title

Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis
Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    bismuth ...

  • Study Participants

    197
This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.
Reduction of signs and symptoms of blepharitis
Study Started
Feb 28
2009
Primary Completion
Jul 31
2009
Study Completion
Aug 31
2009
Last Update
May 20
2011
Estimate

Drug Posiformin 2 %, bibrocathol

A strip of 5 mm eye ointment applied 3 times per day to the eye lid

Drug Placebo Comparator

corresponding vehicle, eye ointment applied to the eye lid

Posiformin 2 % Active Comparator

Eye ointment applied to the eye lid

Placebo Placebo Comparator

corresponding vehicle, eye ointment applied to the eye lid

Criteria 

Inclusion Criteria:

written informed consent
ambulatory male and female patients 18 years of age or older
summarised score of signs and symptoms of blepharitis of 15 or more at baseline

Exclusion Criteria:

different ocular conditions
different system conditions
several concomitant medications
No Results Posted